Findings from a retrospective study involving discharge data on 222,751 women from a variety of hospital settings indicate that during the 6-week post-partum period, women are at higher risk for a number of nonurogenital infections.
Findings from a retrospective study involving discharge data on 222,751 US women from a variety of hospital settings indicate that during the 6-week postpartum period, women are at higher risk for a number of nonurogenital infections, including pneumonia, appendicitis, and cholecystitis.
In fact, cumulative readmission rates were higher in the first 6 weeks after delivery than in the next 20 weeks for all 3 infections: 3.7 versus 0.11, 1.1 versus 0.36, and 6.6 versus 1.7, respectively.
Study authors also found that during the postpartum period, the women who required cesarean delivery were more than twice as likely as those who delivered vaginally to be readmitted to the hospital within the first 6 weeks postpartum and were almost 2.5 times more likely to develop pneumonia than those who delivered vaginally.
Belfort MA, Clark SL, Saade GR, et al. Hospital readmission after delivery: evidence for an increased incidence of nonurogenital infection in the immediate postpartum period. Am J Obstet Gynecol. 2010;202(1):35.e1-7.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More